Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: dermal

Currently viewing:

Administrative data

Endpoint:
short-term repeated dose toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Study period:
11.07.1988 to 12.03.1990
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
comparable to guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1990
Report date:
1990

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 410 (Repeated Dose Dermal Toxicity: 21/28-Day Study)
Deviations:
yes
Remarks:
Limited haematology
GLP compliance:
yes
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Decamethylcyclopentasiloxane
EC Number:
208-764-9
EC Name:
Decamethylcyclopentasiloxane
Cas Number:
541-02-6
Molecular formula:
C10H30O5Si5
IUPAC Name:
2,2,4,4,6,6,8,8,10,10-decamethyl-1,3,5,7,9,2,4,6,8,10-pentoxapentasilecane

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles Rivers Breeding Laboratories, Portage, Michigan
- Age at study initiation: 'young'
- Weight at study initiation: males: 259-286 g; females: 215-263 g
- Fasting period before study: No data
- Housing: Individually in standard stainless steel wire mesh cages of conventional design
- Diet (e.g. ad libitum): Ad libitum
- Water (e.g. ad libitum): Ad libitum
- Acclimation period: Seven days


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ±3
- Humidity (%): 30-70
- Air changes (per hr): No data
- Photoperiod (hrs dark / hrs light): 12/12


IN-LIFE DATES: From: To:

Administration / exposure

Type of coverage:
occlusive
Vehicle:
unchanged (no vehicle)
Details on exposure:
TEST SITE
- Area of exposure: Dorsal area
- % coverage: approx. 10%
- Type of wrap if used: Occluded with plastic wrap
- Time intervals for shavings or clippings: as needed


REMOVAL OF TEST SUBSTANCE
- Washing (if done): No

TEST MATERIAL
- Amount(s) applied (volume or weight with unit): No data
- Constant volume or concentration used: No data


USE OF RESTRAINERS FOR PREVENTING INGESTION: no
Analytical verification of doses or concentrations:
not specified
Duration of treatment / exposure:
28 days
Frequency of treatment:
Once daily for 6 hr/day, 7d/week, for 28 days
Doses / concentrationsopen allclose all
Dose / conc.:
200 mg/kg bw/day (actual dose received)
Dose / conc.:
800 mg/kg bw/day (actual dose received)
Dose / conc.:
1 600 mg/kg bw/day (actual dose received)
No. of animals per sex per dose:
10 per sex in main study groups, 5 per sex in the 2 satellite groups.
Control animals:
other: occluded with plastic wrap, but without test material
Details on study design:
- Dose selection rationale: No data
- Rationale for animal assignment (if not random): random
- Rationale for selecting satellite groups: reversibility of adverse effects (control and 1600 mg/kg bw/day groups)
- Post-exposure recovery period in satellite groups: 28 days
Positive control:
None

Examinations

Observations and examinations performed and frequency:
CAGE SIDE OBSERVATIONS: Yes
- Time schedule: Daily for all groups

DETAILED CLINICAL OBSERVATIONS: No

DERMAL IRRITATION (if dermal study): No

BODY WEIGHT: Yes
- Time schedule for examinations: study initiation, weekly throughout the study and at termination, including the post-exposure rest period.

FOOD CONSUMPTION:
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes


FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: No

WATER CONSUMPTION: No

OPHTHALMOSCOPIC EXAMINATION: Yes
- Time schedule for examinations: study initiation and termination
- Dose groups that were examined: control and high dose group animal

HAEMATOLOGY: Yes
- Time schedule for collection of blood: At study termination
- Anaesthetic used for blood collection: Yes (ketamine HCl)
- Animals fasted: Yes
- How many animals: All animals
- Parameters checked in table 1 were examined.


CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: At study termination
- Animals fasted: Yes
- How many animals: All animals
- Parameters checked in table 1 were examined


URINALYSIS: Yes
- Time schedule for collection of urine: At study termination
- Metabolism cages used for collection of urine: Yes
- Animals fasted: Yes
- Parameters checked in table 1 were examined.


NEUROBEHAVIOURAL EXAMINATION: No
Sacrifice and pathology:
GROSS PATHOLOGY: Yes (see table 2)
HISTOPATHOLOGY: Yes (see table 2)
Other examinations:
None
Statistics:
Body weight, food consumption, hematology, clinical chemistry, urinalysis, organ weights analysed by 1-way ANOVA.
Group means compared with controls using Dunnett's multiple T-test or non-parametric analysis of variance by ranks
where appropriate.

Results and discussion

Results of examinations

Clinical signs:
no effects observed
Dermal irritation:
no effects observed
Mortality:
no mortality observed
Body weight and weight changes:
no effects observed
Food consumption and compound intake (if feeding study):
no effects observed
Food efficiency:
not examined
Water consumption and compound intake (if drinking water study):
not examined
Ophthalmological findings:
no effects observed
Haematological findings:
no effects observed
Clinical biochemistry findings:
no effects observed
Urinalysis findings:
no effects observed
Behaviour (functional findings):
not examined
Organ weight findings including organ / body weight ratios:
no effects observed
Gross pathological findings:
no effects observed
Histopathological findings: non-neoplastic:
no effects observed
Histopathological findings: neoplastic:
not examined
Details on results:
• Body weight: No significant differences were found.
• Food/water consumption: No significant differences were found.
• Description, severity, time of onset and duration of clinical signs: No significant clinical observations or
behavioural changes were reported.
• Ophthalmologic findings incidence and severity: No adverse effects observed.
• Hematological findings incidence and severity: No significant changes were reported.
• Clinical biochemistry findings incidence and severity: No significant changes were reported for clinical chemistry or
urinalysis results.
• Mortality and time to death: No unscheduled early deaths occurred during this study.
• Gross pathology incidence and severity: There were no apparent treatment-related effects noted at gross necropsy.
• Organ weight changes: No significant changes were reported
• Histopathology incidence and severity: No significant dose-related findings were reported for either terminal or
recovery group sacrifices.

Effect levels

open allclose all
Dose descriptor:
NOAEL
Effect level:
>= 1 600 mg/kg bw/day (actual dose received)
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: No systemic effects observed.
Dose descriptor:
NOAEL
Effect level:
>= 1 600 mg/kg bw/day (actual dose received)
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: No local effects observed.

Target system / organ toxicity

Critical effects observed:
no

Applicant's summary and conclusion

Conclusions:
Dermal administration of undiluted D5 under occlusive conditions over a 28-day period at doses up to and including 1600 mg/kg bw/day resulted in no adverse effects on survival, body weight, food consumption, clinical observations, clinical pathology, hematology, ophthalmoscopy, organ weights, or gross or microscopic pathology (study reliability score 1).